Companies and products
Wandercraft
Updates on Wandercraft's robotics products, models, research, funding, applications, and partnerships.
4 selected · 0 in the last 30 days
Wandercraft ·
Wandercraft Acquires Ekso Bionics to Form Medical Exoskeleton Company
Wandercraft announced the acquisition of Ekso Bionics from a subsidiary of ChronoScale Holdings; the deal was signed and closed simultaneously, with financial terms undisclosed.
Wandercraft ·
Wandercraft's self-balancing personal exoskeleton Eve officially launches commercially in the US
Wandercraft announced the official US commercial launch of its personal exoskeleton Eve, calling it the first FDA-cleared self-balancing personal exoskeleton that does not restrict the neurological level of spinal cord injury, allowing users to stand and perform daily activities hands-free without crutches. The access process includes clinical evaluation, a physician's prescription, individualized customization, and training; Medicare covers it under HCPCS code K1007, NSM supports delivery through more than 180 locations, and it is backed by a 16-participant training study published in JoVE.
Wandercraft ·
Wandercraft's self-balancing personal exoskeleton Eve wins FDA clearance, US launch planned for September 17, 2026
Wandercraft announced that its personal self-balancing exoskeleton Eve has received FDA clearance for eligible wheelchair users with spinal cord injuries at any level, enabling them to stand, walk, and perform daily activities with both hands free, for indoor use and on adjacent open flat surfaces.
Wandercraft ·
Wandercraft Personal Exoskeleton Launches Pivotal Clinical Trial
Wandercraft announced the launch of a pivotal clinical trial for its Personal Exoskeleton, evaluating the safety and effectiveness of this self-balancing personal exoskeleton in improving walking independence for patients with spinal cord injury (SCI).